OSHKOSH CORP·4

Dec 5, 4:53 PM ET

Sims Robert H 4

4 · OSHKOSH CORP · Filed Dec 5, 2019

Insider Transaction Report

Form 4
Period: 2019-12-03
Sims Robert H
EVP & Chief HR Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-12-03$89.89/sh+3.633$32711,907.8 total
  • Tax Payment

    Common Stock

    2019-12-03$89.89/sh2$18011,906.594 total
  • Tax Payment

    Common Stock

    2019-12-03$89.89/sh2$18011,905.8 total
  • Exercise/Conversion

    Common Stock

    2019-12-03$89.89/sh+3.597$32311,910.191 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-033.6330 total
    Common Stock (3.633 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-032.794839.832 total
    Common Stock (2.794 underlying)
  • Exercise/Conversion

    Common Stock

    2019-12-03$89.89/sh+2.794$25111,908.594 total
  • Tax Payment

    Common Stock

    2019-12-03$89.89/sh2$18011,908.191 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-12-033.5972,164.714 total
    Common Stock (3.597 underlying)
Footnotes (7)
  • [F1]Dividend paid on Restricted Stock Units vested and distributed on November 21, 2019 which fell between dividend record date and dividend payment date.
  • [F2]Dividend paid on Restricted Stock Units vested and distributed on November 20, 2019 which fell between dividend record date and dividend payment date.
  • [F3]Dividend paid on Restricted Stock Units vested and distributed on November 19, 2019 which fell between dividend record date and dividend payment date.
  • [F4]Each Restricted Stock Unit represents a contingent right to receive one share of OSK common stock.
  • [F5]Restricted Stock Unit Award vests in one-third (1/3) annual increments commencing on 11/21/2017.
  • [F6]Restricted Stock Unit Award vests in one-third (1/3) annual increments commencing on 11/20/2018.
  • [F7]Restricted Stock Unit Award vests in one-third (1/3) annual increments commencing on 11/19/2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT